# asxan.ai · llms-full.txt · per-page comprehensive listing

> Full per-page metadata for AI bot consumption. Companion to https://asxan.ai/llms.txt (index).
> Last updated 2026-05-30 · 154 pages enumerated · 696 JSON-LD blocks across corpus.

## Site overview

- **Content**: Evidence-first ingredient science library — ingredient hubs, evidence long-form articles, health goal stacks, lifestyle nutrition guides, structured NC/FC APIs.
- **Multi-language coverage**:
  - English (canonical): 98 indexable pages
  - Portuguese (Brazil): 30 translated pages including 6 evidence articles, 14 goal stacks, 9 lifestyle guides
  - Spanish: 4 ingredient hub pages (initial coverage)
- **Cross-market regulatory framing**:
  - FDA (US): DSHEA + NDI + 21 CFR 111 cGMP + authorized health claims (verbatim in NC API authorized_claims field)
  - EFSA (EU): Reg 432/2012 + 440/2011 authorized claims + Novel Food 2015/2283
  - ANVISA (Brazil): RDC 243/2018 dietary supplement framework + IN 28/2018 alegações funcionais
  - TGA (Australia): listed supplements with permissible upper intake limits
- **Cluster topology**: 6 evidence articles bidirectionally linked to 5 ingredient hubs + 2 T0 cluster hubs + 3 goal pages
- **NC API**: 20 ingredient cards with 4-axis public knowledge (mechanism + target + use_case + body_system). Commercial formulation IP not exposed.
- **Editorial approach**: tier-graded evidence (A/B/C), negative-honest disclosure of null trials and contradictions, reverse-correction transparency for any in-house PMID drift or attribution error.

## Format
Each page block:
- URL (canonical · https://asxan.ai prefix)
- Title
- Description (meta description · ≤300 chars)
- Schema.org @type list (JSON-LD blocks present in HTML head)
- PMID count (estimated by regex match · educational reference only)

AI crawlers consume this file to identify priority pages, cluster topology, and Schema markup coverage without fetching all 96 pages individually.

## Core pages (entry + navigation) (4 pages)

### https://asxan.ai/

**Title**: ASXAN · Evidence-first ingredient science hub
**Description**: Evidence-first ingredient hub. 28 deep ingredient pages + 6 long-form articles + 14 goal stacks + 9 lifestyle guides, PubMed-verified.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebSite
**PMID references**: 0

### https://asxan.ai/about/

**Title**: About · ASXAN Group · Evidence-first nutrition science hub
**Description**: About ASXAN Group · evidence-first ingredient science hub · editorial principles · cross-market regulatory framing (FDA · EFSA · ANVISA).
**Schema @type**: AboutPage · BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/faq/

**Title**: Frequently Asked Questions
**Description**: 472 Q&A on NAD+, carotenoids, omega-3, protein, vitamin E, beta-glucan — PubMed-verified, every answer source-linked.
**Schema @type**: BreadcrumbList · EducationalOrganization · FAQPage · Organization · ResearchOrganization
**PMID references**: 97

### https://asxan.ai/science/

**Title**: Science · ASXAN research focus & methodology
**Description**: ASXAN scientific capability · carotenoid + yeast protein + NAD+ family platforms · PubMed-verified · FDA/EFSA/ANVISA cross-market regulatory clarity.
**Schema @type**: AboutPage · Article · BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

## Evidence Long-Form Articles (Tier A · peer cluster topology) (7 pages)

### https://asxan.ai/blog/nad-25-year-rct-history-evidence/

**Title**: NAD+ Anti-Aging Evidence · 25 Years of Randomized Trials (1999-2026)
**Description**: A chronological reading of the NAD+ precursor and reduced-cofactor randomized trial history from Forsyth 1999 through Zhang 2025 meta-analysis, covering NADH…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 62

### https://asxan.ai/blog/natural-vs-synthetic-astaxanthin-evidence-comparison/

**Title**: Natural Haematococcus vs Synthetic Astaxanthin · A Chemistry, Bioavailability and Clinical Evidence Comparison
**Description**: Evidence-first comparison of natural Haematococcus pluvialis astaxanthin and chemically synthesised astaxanthin across stereochemistry, esterification, native…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · Organization · ResearchOrganization
**PMID references**: 56

### https://asxan.ai/blog/nmn-vs-nr-decision-tree-evidence/

**Title**: NMN vs NR · The 2026 NAD+ Precursor Decision Tree (Evidence-Based)
**Description**: Side-by-side comparison of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) across five dimensions — absorption, randomized trial portfolio,…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 42

### https://asxan.ai/blog/omega-3-evidence-history-cardiovascular-and-inflammation/

**Title**: Omega-3 Evidence: 25 Years of Cardiovascular RCTs and the EPA Inflammation Science
**Description**: Evidence-honest long read on what 86 randomized trials in 162,000 participants actually established — and what they did not — about marine omega-3,…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · Organization · ResearchOrganization
**PMID references**: 56

### https://asxan.ai/blog/protein-source-decision-tree-whey-vs-yeast-focus/

**Title**: Protein Source Decision Tree · DIAAS Across 5 Forms + Whey vs Yeast Deep Comparison
**Description**: Educational evidence hub guide comparing whey, casein, soy, pea, and yeast protein using the FAO 2013 DIAAS framework, with a 6-dimension head-to-head between…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · Organization · ResearchOrganization
**PMID references**: 50

### https://asxan.ai/blog/reduced-nadh-vs-nmnh-evidence/

**Title**: Reduced NADH vs NMNH · Classical Cofactor vs Emerging Reduced Precursor (Evidence Comparison)
**Description**: Side-by-side comparison of stabilized oral NADH (the classical reduced NAD cofactor with 25 years of randomized trial history) and NMNH (the 2021-synthesized…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 34

### https://asxan.ai/blog/

**Title**: Evidence Long-Form Articles · 6 deep-dive essays · PubMed-verified
**Description**: Six evidence long-form articles: decision trees, 25-year RCT histories, head-to-head comparisons. 144 PMID across corpus, 35 reverse-correction cases disclosed.
**Schema @type**: Blog · BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

## Ingredient Pages (T0 cluster anchors + detail) (60 pages)

### https://asxan.ai/ingredients/akkermansia/

**Title**: Akkermansia muciniphila · Evidence-First Lite Reference
**Description**: Akkermansia muciniphila overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 1

### https://asxan.ai/ingredients/algal-oil/

**Title**: Algal Oil · Evidence-First Fact Sheet
**Description**: Evidence-first reference on algal oil — closed-system-fermentation DHA from Schizochytrium / Crypthecodinium / Ulkenia / Nannochloropsis microalgae.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 18

### https://asxan.ai/ingredients/ashwagandha/

**Title**: Ashwagandha · Evidence-First Lite Reference
**Description**: Ashwagandha overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/astaxanthin/

**Title**: Astaxanthin · Evidence-First Fact Sheet
**Description**: Astaxanthin is a red-orange xanthophyll carotenoid from Haematococcus pluvialis microalgae and marine organisms.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 70

### https://asxan.ai/ingredients/b12/

**Title**: Vitamin B12 · Evidence-First Lite Reference
**Description**: Vitamin B12 overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/bcaa/

**Title**: BCAA (Branched-Chain Amino Acids) · Evidence-First Lite Reference
**Description**: BCAA (Branched-Chain Amino Acids) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/berberine/

**Title**: Berberine · Evidence-First Lite Reference
**Description**: Berberine overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/beta-carotene/

**Title**: β-Carotene · Evidence-First Educational Reference (Smoker-Warning Exemplar)
**Description**: NIH-ODS / MedlinePlus-style evidence-first educational reference on β-carotene: provitamin A chemistry, the 12:1 dietary RAE conversion (vs 2:1 supplement),…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 36

### https://asxan.ai/ingredients/beta-glucan/

**Title**: Beta-Glucan · Evidence-First Fact Sheet
**Description**: Beta-glucan is a family of polysaccharides with two main structural types — cereal β-1,3/1,4-glucan (oats / barley) and yeast / mushroom β-1,3/1,6-glucan —…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 19

### https://asxan.ai/ingredients/biotin/

**Title**: Biotin (Vitamin B7) · Evidence-First Lite Reference
**Description**: Biotin (Vitamin B7) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/carotenoids/

**Title**: Carotenoids (Cluster Hub · 8 Core Compounds) · Evidence-First Fact Sheet
**Description**: Educational cluster hub on the carotenoid family (700+ natural pigments · 8 nutritionally / clinically important compounds): carotenes vs xanthophylls split,…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 78

### https://asxan.ai/ingredients/casein-protein/

**Title**: Casein Protein · Evidence-First Sub-Page
**Description**: Evidence-first reference on the slow-release dairy protein casein: gastric curdling physical chemistry, the five casein-specific human trials (Boirie 1997…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 17

### https://asxan.ai/ingredients/choline/

**Title**: Choline · Evidence-First Lite Reference
**Description**: Choline overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/collagen-peptides/

**Title**: Collagen Peptides · Evidence-First Lite Reference
**Description**: Collagen Peptides overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/coq10/

**Title**: CoQ10 (Ubiquinone) · Evidence-First Lite Reference
**Description**: CoQ10 (Ubiquinone) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/creatine/

**Title**: Creatine · Evidence-First Lite Reference
**Description**: Creatine overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/curcumin/

**Title**: Curcumin · Evidence-First Lite Reference
**Description**: Curcumin overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/fish-oil/

**Title**: Fish Oil (EPA + DHA) · Evidence-First Sub-Page
**Description**: Evidence-first reference on fish-derived omega-3 (EPA + DHA): marine sources (anchovy / sardine / mackerel / salmon / cod liver), refining and concentration…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 17

### https://asxan.ai/ingredients/flaxseed-ala/

**Title**: Flaxseed (ALA) · Plant Omega-3 Source · Evidence Review
**Description**: Evidence-based review of flaxseed: ALA content, conversion to EPA/DHA, cardiovascular evidence (Pan 2012 · FLAX-PAD · Ursoniu meta), lignans (SDG), fiber, and…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 14

### https://asxan.ai/ingredients/folate/

**Title**: Folate (Vitamin B9) · Evidence-First Lite Reference
**Description**: Folate (Vitamin B9) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/fucoxanthin/

**Title**: Fucoxanthin · Evidence-First Fact Sheet
**Description**: Fucoxanthin is an allenic xanthophyll carotenoid from brown seaweed and marine microalgae with rct-supported evidence for supporting healthy markers of…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 16

### https://asxan.ai/ingredients/hyaluronic-acid/

**Title**: Hyaluronic Acid · Evidence-First Lite Reference
**Description**: Hyaluronic Acid overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/iron/

**Title**: Iron · Evidence-First Lite Reference
**Description**: Iron overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/krill-oil/

**Title**: Krill Oil (Antarctic Krill · Euphausia superba) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on Antarctic krill oil: phospholipid EPA+DHA form, naturally co-occurring astaxanthin, head-to-head bioavailability vs.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 30

### https://asxan.ai/ingredients/l-theanine/

**Title**: L-Theanine · Evidence-First Lite Reference
**Description**: L-Theanine overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/lutein/

**Title**: Lutein (Macular Xanthophyll · β,ε-Carotene-3,3′-diol) · Evidence-First Sub-Page
**Description**: Evidence-first reference on lutein — the macular xanthophyll humans cannot synthesize. Covers the AREDS2 trial (n=4,203) and its honest reading (primary…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 36

### https://asxan.ai/ingredients/lycopene/

**Title**: Lycopene · Evidence-First Fact Sheet
**Description**: Evidence-first reference on lycopene — the open-chain, acyclic, non-provitamin-A carotenoid: structural quirk (no β-ionone ring), all-trans vs cis isomers,…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 32

### https://asxan.ai/ingredients/magnesium/

**Title**: Magnesium · Evidence-First Lite Reference
**Description**: Magnesium overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/mct/

**Title**: MCT (Medium-Chain Triglycerides) · Evidence-First Lite Reference
**Description**: MCT (Medium-Chain Triglycerides) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/multivitamin/

**Title**: Multivitamin · Evidence-First Lite Reference
**Description**: Multivitamin overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/nad-cluster/

**Title**: NAD+ Precursor Cluster · Evidence-First Hub
**Description**: NAD+ precursor family hub: comparative evidence across NMN, NR, niacinamide, niacin, NADH. Educational, not medical advice.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 29

### https://asxan.ai/ingredients/nad-plus/

**Title**: NAD+ Direct Supplementation · Background and Evidence Limits
**Description**: NAD+ direct supplementation: why the 663-dalton dinucleotide is poorly orally absorbed and what the evidence-supported alternatives look like.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 45

### https://asxan.ai/ingredients/nadh/

**Title**: NADH (Reduced Nicotinamide Adenine Dinucleotide) · Evidence-First Fact Sheet
**Description**: NADH (reduced NAD) evidence sheet: chronic fatigue (Forsyth 1999), jet-lag cognition (Birkmayer 2002), Alzheimer (Demarin 2004). 25 years of DSHEA safety.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 26

### https://asxan.ai/ingredients/nervonic-acid/

**Title**: Nervonic Acid · Evidence-First Lite Reference
**Description**: Nervonic Acid overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/nmn/

**Title**: NMN (β-Nicotinamide Mononucleotide) · Evidence-First Fact Sheet
**Description**: NMN (β-nicotinamide mononucleotide) evidence sheet: 13 human RCTs, dosing, regulatory status across US, EU, Brazil. Educational only.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 34

### https://asxan.ai/ingredients/nmnh/

**Title**: NMNH (Reduced NMN) · Tier C Emerging Research Compound
**Description**: NMNH (reduced NMN) Tier C emerging research compound: 0 human RCTs as of 2026; preclinical findings and regulatory void.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalGuideline · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 16

### https://asxan.ai/ingredients/omega-3/

**Title**: Omega-3 (EPA / DHA / ALA) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on omega-3 fatty acids (EPA, DHA, ALA): mechanisms, meta-analysis-supported benefits, negative trial findings (VITAL · STRENGTH · AMD…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 36

### https://asxan.ai/ingredients/pea-protein/

**Title**: Pea Protein · Evidence-First Sub-Page
**Description**: Evidence-first reference on pea protein (Pisum sativum, yellow split pea, PPI 80–90%): three head-to-head human trials vs whey (Babault 2015 · Banaszek 2019 ·…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 9

### https://asxan.ai/ingredients/phosphatidylserine/

**Title**: Phosphatidylserine (PS) · Evidence-First Lite Reference
**Description**: Phosphatidylserine (PS) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/plant-protein/

**Title**: Plant Protein Blend (Pea + Rice ± Hemp / Soy / Sacha Inchi / Pumpkin / Canola) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on multi-source plant protein blends: amino-acid complementarity (DIAAS 0.90–1.0), the four canonical formulations, RCT cluster on…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 17

### https://asxan.ai/ingredients/pqq/

**Title**: PQQ (Pyrroloquinoline Quinone) · Evidence-First Lite Reference
**Description**: PQQ (Pyrroloquinoline Quinone) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/probiotics/

**Title**: Probiotics · Evidence-First Lite Reference
**Description**: Probiotics overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/protein/

**Title**: Protein (Whey · Casein · Soy · Pea · Plant Blend · Yeast · Hemp · Rice · Microalgae · Mycoprotein) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on dietary protein as a macronutrient class: mechanisms, meta-analysis-supported benefits, rebuttals of long-feared risks (kidney ·…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 50

### https://asxan.ai/ingredients/protein/hydrolyzed/

**Title**: Hydrolyzed Protein · Evidence-First Fact Sheet
**Description**: Hydrolyzed protein source page for sports nutrition and absorption-oriented evidence mapping. Wave 1 build pending.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/resveratrol/

**Title**: Resveratrol · Evidence-First Lite Reference
**Description**: Resveratrol overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/saw-palmetto/

**Title**: Saw Palmetto · Evidence-First Lite Reference
**Description**: Saw Palmetto overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/soy-isoflavones/

**Title**: Soy Isoflavones · Evidence-First Lite Reference
**Description**: Soy Isoflavones overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/soy-protein/

**Title**: Soy Protein (SPI / SPC / TVP) · Evidence-First Fact Sheet
**Description**: Evidence-based reference on soy protein (Isolate / Concentrate / Textured) and its isoflavone co-content: DIAAS 0.84–0.91, LDL reduction (Blanco Mejia 2019),…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 21

### https://asxan.ai/ingredients/spermidine/

**Title**: Spermidine · Evidence-First Lite Reference
**Description**: Spermidine overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/tocopherols/

**Title**: Tocopherols (Vitamin E α / β / γ / δ-Tocopherol) · Evidence-First Sub-Page
**Description**: Evidence-first reference on the tocopherol family of vitamin E: the four isomers (α/β/γ/δ), natural d-α-tocopherol (RRR) vs synthetic dl-α-tocopherol…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 14

### https://asxan.ai/ingredients/tocotrienols/

**Title**: Tocotrienols (α / β / γ / δ-Tocotrienol) · Evidence-First Sub-Page
**Description**: Evidence-first reference on tocotrienols (the unsaturated vitamin E branch): four isomers (α / β / γ / δ-T3), three plant sources (annatto vs palm vs rice…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 18

### https://asxan.ai/ingredients/type-2-collagen/

**Title**: Type II Collagen · Evidence-First Lite Reference
**Description**: Type II Collagen overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/urolithin-a/

**Title**: Urolithin A · Evidence-First Lite Reference
**Description**: Urolithin A overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/vitamin-d3/

**Title**: Vitamin D3 · Evidence-First Fact Sheet
**Description**: Vitamin D3 (cholecalciferol) is a secosteroid hormone precursor with meta-analysis-supported evidence for bone mineral density, daily-dose respiratory immune…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 32

### https://asxan.ai/ingredients/vitamin-e/

**Title**: Vitamin E (Tocopherols + Tocotrienols) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on the eight-chemical vitamin E family (4 tocopherols + 4 tocotrienols): α-TTP biology, RDA + EFSA 2024 upper limit revision, IU↔mg…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 51

### https://asxan.ai/ingredients/vitamin-k2/

**Title**: Vitamin K2 (Menaquinone) · Evidence-First Lite Reference
**Description**: Vitamin K2 (Menaquinone) overview and evidence tier · full fact sheet building in Wave 1 D5.
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/ingredients/whey-protein/

**Title**: Whey Protein (WPC · WPI · WPH · Native Whey) · Evidence-First Sub-Page
**Description**: Evidence-first reference on whey protein: refining from milk to WPC/WPI/WPH/native whey, four whey-specific mechanisms (leucine ~11% · ~8–10 g/h digestion ·…
**Schema @type**: BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 28

### https://asxan.ai/ingredients/yeast-protein/

**Title**: Yeast Protein (Saccharomyces cerevisiae) · Evidence-First Fact Sheet
**Description**: Evidence-first reference on yeast protein (Saccharomyces cerevisiae): three-layer evidence transparency (direct yeast RCTs · mycoprotein analogy · β-glucan…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 13

### https://asxan.ai/ingredients/zeaxanthin/

**Title**: Zeaxanthin (3R,3′R · meso-Zeaxanthin · macular xanthophyll) · Evidence-First Sub-Page
**Description**: Evidence-first reference on zeaxanthin, the macular xanthophyll: three stereoisomers (lutein vs 3R,3′R-zeaxanthin vs meso-zeaxanthin), the radial macular…
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · FAQPage · MedicalWebPage · Organization · ResearchOrganization
**PMID references**: 40

### https://asxan.ai/ingredients/

**Title**: Ingredients · Evidence-First Library · 58 pages by body system
**Description**: 58 evidence-first ingredient pages by body system. Carotenoids, Omega-3, NAD+, Protein, Vitamins, Minerals — all PubMed-verified across FDA/EFSA/ANVISA.
**Schema @type**: BreadcrumbList · CollectionPage · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

## Health Goal Stacks (15 pages)

### https://asxan.ai/goals/

**Title**: Goals · 14 Evidence-First Health Goal Stacks
**Description**: 14 evidence-first health goal stacks. Longevity, heart, cognition, eye, joint, skin, gut, sports, inflammation — cross-linked to PubMed-verified ingredients.
**Schema @type**: BreadcrumbList · CollectionPage · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/goals/athletic-performance/

**Title**: Athletic Performance · Sports Nutrition Stack
**Description**: Athletic performance · protein 1.6 g/kg/day (Morton 2018); whey acute MPS advantage (Tang 2009); astaxanthin fatigue meta; creatine, BCAA Lite stubs.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 26

### https://asxan.ai/goals/cognitive-support/

**Title**: Cognitive Support · Brain Health Stack
**Description**: Cognitive support · DHA memory positive in mild complaints; Alzheimer null; astaxanthin cognition unsettled. PS/nervonic/PQQ Lite stubs.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 13

### https://asxan.ai/goals/eye-protection/

**Title**: Eye Protection · Lutein + Zeaxanthin Carotenoid Evidence Stack
**Description**: Eye · AREDS2 Chew 2013 PMID 23644932 lutein+zeaxanthin AMD; Wilson 2021 PMID 34157098 MPOD meta; CARET/ATBC β-carotene smoker risk disclosed.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 11

### https://asxan.ai/goals/glp-1-companion/

**Title**: GLP-1 Companion · Nutrition Support for GLP-1 Medication Users
**Description**: GLP-1 companion · protein 1.6 g/kg/day lean-mass preservation; pre-meal whey GLP-1/GIP release (Jakubowicz 2014); omega-3 TG lowering. BCAA Lite stub.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 21

### https://asxan.ai/goals/gut-digestion/

**Title**: Gut & Digestion · Fiber + Prebiotic + Strain-Specific Evidence Stack
**Description**: Gut stack · Reynolds 2019 PMID 30638909 Lancet fiber; Jovanovski 2018 PMID 30239559 psyllium LDL; Vandeputte 2017 inulin; Suez 2018 probiotic.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 8

### https://asxan.ai/goals/hair-nail/

**Title**: Hair & Nail · Collagen Peptide Nail + Biotin Honest Framework
**Description**: Hair & nail · Hexsel 2017 PMID 28786550 collagen NAIL; Lim 2010 PMID 24575202 tocotrienol; Patel 2017 PMID 28879195 biotin review; troponin disclosed.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 9

### https://asxan.ai/goals/heart-health/

**Title**: Heart Health · Cardiovascular Support Stack
**Description**: Heart health stack · omega-3 conditional CV (REDUCE-IT positive; VITAL null; STRENGTH AF signal); astaxanthin partial; CoQ10 and K2 are Lite stubs.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 11

### https://asxan.ai/goals/inflammation-relief/

**Title**: Inflammation Balance · Omega-3 + Curcumin + Carotenoid Evidence Stack
**Description**: Inflammation stack · Goldberg 2007 PMID 17335973 omega-3 RA; Daily 2016 PMID 27533649 curcumin; Yu 2020 PMID 32680575 Boswellia; Hill 2021 tart cherry.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 6

### https://asxan.ai/goals/joint-bone/

**Title**: Joint & Bone Health · Lifelong Mobility Evidence Stack
**Description**: Joint + Bone · LeBoff 2022 PMID 35939577 VITAL null; Kong 2022 D+Ca deficient; Lin 2023 PMID 37717022 collagen OA; Lugo 2016 UC-II; Knapen MK-7.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 11

### https://asxan.ai/goals/longevity-stack/

**Title**: Longevity Stack · Healthy Aging Support
**Description**: Longevity stack · NMN raises NAD+ in RCTs (Yi 2022); astaxanthin Layer A; spermidine, resveratrol, urolithin A are Lite stubs pending build.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 18

### https://asxan.ai/goals/menopause-support/

**Title**: Menopause Wellness · Hormone-Balance Evidence Stack
**Description**: Menopause · Taku 2012 PMID 22433977 soy hot-flash; Kanadys 2021 PMID 33920485 red clover; Leach 2012 PMID 22972105 black cohosh Cochrane; MK-7 BMD.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 8

### https://asxan.ai/goals/reproductive-health/

**Title**: Reproductive Wellness · Zinc + CoQ10 + L-Carnitine Sperm Parameters Stack
**Description**: Reproductive · Salas-Huetos 2018 PMID 30462179 sperm SR-MA; Lafuente 2013 CoQ10 + Lenzi 2003 L-carnitine; de Ligny 2022 Cochrane very-low certainty.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 18

### https://asxan.ai/goals/skin-beauty/

**Title**: Skin Beauty · Astaxanthin + Collagen Peptides Evidence Stack
**Description**: Skin beauty · Zhou 2021 PMID 34578794 astaxanthin meta; de Miranda 2021 PMID 33742704 collagen meta; Kawada 2014 oral HA; Stahl 2001 lycopene MED.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 15

### https://asxan.ai/goals/weight-management/

**Title**: Healthy Weight Management Stack
**Description**: Weight management · fucoxanthin metabolic-syndrome RCT; yeast protein PDCAAS ~1.00; whey body composition (Baer 2011). Berberine Lite stub.
**Schema @type**: BreadcrumbList · EducationalOrganization · Organization · ResearchOrganization · WebPage
**PMID references**: 19

## Lifestyle Nutrition Guides (10 pages)

### https://asxan.ai/lifestyles/

**Title**: Lifestyles · 9 Evidence-First Nutrition Guides
**Description**: 9 evidence-first lifestyle nutrition guides. Keto, plant-based, IF, pregnancy, menopause, senior 60+, GLP-1, athletic, high-stress — PubMed cross-linked.
**Schema @type**: BreadcrumbList · CollectionPage · EducationalOrganization · Organization · ResearchOrganization
**PMID references**: 0

### https://asxan.ai/lifestyles/athletic-performance/

**Title**: Athletic Performance · Nutrition Gap Analysis & Supplement Strategy
**Description**: Athletic-performance · Morton 2018 PMID 28698222 protein 1.6g/kg; Kreider 2017 creatine; Guest 2021 caffeine; Saunders 2017 β-alanine; Brown 2021 astaxanthin.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 18

### https://asxan.ai/lifestyles/glp-1-companion/

**Title**: GLP-1 Companion · Nutrition Gap Analysis & Supplement Strategy
**Description**: GLP-1 companion · Morton 2018 protein 1.6g/kg; Bauer 2015 PROVIDE; Jakubowicz 2014 whey premeal; Reynolds 2019 fiber. Companion, NOT substitute for GLP-1 Rx.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 17

### https://asxan.ai/lifestyles/high-stress/

**Title**: High Stress · Nutrition Gap Analysis & Supplement Strategy
**Description**: High-stress · Salve 2019 ashwagandha PMID 32021735; Chandrasekhar 2012 KSM-66; Ishaque 2012 rhodiola; Boyle 2017 magnesium; Hidese 2019 L-theanine; melatonin.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 6

### https://asxan.ai/lifestyles/intermittent-fasting/

**Title**: Intermittent Fasting · Nutrition Gap Analysis & Supplement Strategy
**Description**: IF · Patterson 2017 PMID 28715993; de Cabo 2019 NEJM; Cienfuegos 2020 4/6h TRF; Welton 2020 SR; Morton 2018 protein 1.6g/kg; Reynolds 2019 fiber.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 16

### https://asxan.ai/lifestyles/keto/

**Title**: Keto Diet · Nutrition Gap Analysis & Supplement Strategy
**Description**: Keto · Skartun 2025 keto-flu electrolyte scoping; Fortier 2021 MCT MCI; Cox 2016 ketone ester athletes; Patikorn 2023 LDL caveat. Educational.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 12

### https://asxan.ai/lifestyles/menopause/

**Title**: Menopause Lifestyle · Nutrition Gap Analysis & Supplement Strategy
**Description**: Menopause · Taku 2012 soy isoflavone hot flash; Knapen 2013 MK-7 BMD; Weaver 2016 NOF Ca+D3 fracture; Leach 2012 black cohosh insufficient. Adjunct framework.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 12

### https://asxan.ai/lifestyles/plant-based/

**Title**: Plant-Based Diet · Nutrition Gap Analysis & Supplement Strategy
**Description**: Plant-based · Pawlak 2013 B12 vegan; Tripkovic 2012 D3>D2; Lim 2021 plant vs animal protein; López-Moreno 2025 vegan iron; Simon 2025 vegan Zn/Se.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 15

### https://asxan.ai/lifestyles/pregnancy/

**Title**: Pregnancy · Nutrition Gap Analysis & Supplement Strategy
**Description**: Pregnancy · MRC 1991 PMID 1677062 folate NTD 72%; Middleton 2018 omega-3 preterm; Peña-Rosas iron; Caudill 2018 choline 930mg. Discuss with obstetric team.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 9

### https://asxan.ai/lifestyles/senior-60-plus/

**Title**: Senior 60+ · Nutrition Gap Analysis & Supplement Strategy
**Description**: Senior 60+ · Bauer 2015 PROVIDE; Morton 2018 protein threshold; LeBoff 2022 VITAL fracture null in replete adults; DHA memory. B12 Lite stub.
**Schema @type**: Article · BreadcrumbList · EducationalOrganization · ItemList · Organization · ResearchOrganization
**PMID references**: 28

---

## AI Crawl Optimization Notes

- All 96 pages expose canonical URL + meta description + Schema.org JSON-LD (343 blocks · avg 3.57/page · 0 parse errors).
- Cluster topology: 6 evidence articles cross-link to peer evidence (MedicalScholarlyArticle @id + about + isPartOf); 5 ingredient hubs reverse-link to evidence articles (subjectOf / mentions); 3 goal pages (longevity-stack / heart-health / cognitive-support) reverse-link to evidence; 2 T0 cluster hubs (NAD+ cluster + Carotenoids family).
- T0 cluster anchor ingredients (astaxanthin / omega-3 / whey-protein / carotenoids / nad-cluster) and Layer A NAD+ family (nmn / nadh / nmnh / nad-plus / nad-cluster) carry sitemap priority 0.9-1.0 with weekly changefreq.
- 30 User-agent directives in robots.txt with explicit allow for GPTBot · OAI-SearchBot · ClaudeBot · anthropic-ai · claude-web · PerplexityBot · Perplexity-User · Google-Extended · CCBot · Bytespider · Applebot-Extended · Meta-ExternalAgent · Amazonbot · YouBot · cohere-ai · MistralAI-User · Kagibot · Diffbot · DuckAssistBot · PhindBot + 5 traditional search engines.
- /explore/ /api/ /_validation/ /_specs/ disallowed (faceted nav + internal validation paths).

## Cluster Topology Graph

Evidence cluster (5 of 6 articles bridged · 1 standalone):
- NAD+ axis: nad-25-year ↔ nmn-vs-nr ↔ reduced-nadh-vs-nmnh (3 articles · 3 bidirectional edges)
- Carotenoid + CV bridge: natural-vs-synthetic-astaxanthin ↔ omega-3-evidence-history (2 articles · 1 bidirectional edge)
- Cross-cluster bridge: natural-vs-synthetic-astaxanthin → nad-25-year (1 directional edge · oxidative stress overlap)
- Standalone: protein-source-decision-tree-whey-vs-yeast-focus (1 article · 0 peer edge)

Ingredient ↔ Evidence reverse cycle (5 hubs · 8 reverse edges):
- ingredients/astaxanthin → blog/natural-vs-synthetic-astaxanthin-evidence-comparison (1 edge)
- ingredients/nmn → blog/nad-25-year + blog/nmn-vs-nr + blog/reduced-nadh-vs-nmnh (3 edges)
- ingredients/omega-3 → blog/omega-3-evidence-history (1 edge)
- ingredients/whey-protein → blog/protein-source-decision-tree (1 edge)
- ingredients/nadh → blog/reduced-nadh-vs-nmnh + blog/nad-25-year (2 edges)

T0 cluster hub ↔ Evidence (2 hubs · 4 edges):
- ingredients/nad-cluster → blog/nad-25-year + blog/nmn-vs-nr + blog/reduced-nadh-vs-nmnh (3 edges)
- ingredients/carotenoids → blog/natural-vs-synthetic-astaxanthin (1 edge)

Goal page ↔ Evidence (3 pages · 8 edges):
- goals/longevity-stack → 3 evidence (NAD axis + astaxanthin)
- goals/heart-health → 2 evidence (omega-3 + astaxanthin CV)
- goals/cognitive-support → 3 evidence (NAD + omega-3 + NADH)